Insight Program

Insight Program (Tampa, FL) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The facility's programming is outpatient (PHP, IOP), not residential. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.

Care levels at Insight Program

Level-of-care documentation: Insight Program is an outpatient-focused program (PHP, IOP) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Under MHPAEA 2024 medical-necessity criteria disclosure, plan-specific criteria for each of these levels must be available to patients upon request. Mismatch between documented clinical need and offered level of care is a common source of authorization denial.

Insurance and payment

Payment and insurance posture: Insight Program operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.

Specialty programming

The facility's documented specialty programming includes: Adolescents, Young adults, Adult women. Evaluation of specialty-program alignment requires documented review of clinical team credentials, specialty-specific programming hours, and integrated assessment protocols. Specialty designation without documented clinical infrastructure is a recognized marketing pattern in the sector.

Before you call

Pre-admission due-diligence for Insight Program: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via FL behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether Insight Program offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.